A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby‐Arnon(Broad Institute), Parin Shah(Dana-Farber Cancer Institute), Michael S. Cuoco(Broad Institute), Christopher Rodman(Broad Institute), Mei-Ju Su(Dana-Farber Cancer Institute), Johannes C. Melms(Dana-Farber Cancer Institute), Rachel Leeson(Dana-Farber Cancer Institute), Abhay Kanodia(Dana-Farber Cancer Institute), Shaolin Mei(Harvard University), Jia‐Ren Lin(Harvard University), Shu Wang(Harvard University), Bokang Rabasha(Dana-Farber Cancer Institute), David Liu(Dana-Farber Cancer Institute), Gao Zhang(The Wistar Institute), Claire Margolais(Dana-Farber Cancer Institute), Orr Ashenberg(Broad Institute), Patrick A. Ott(Dana-Farber Cancer Institute), Elizabeth I. Buchbinder(Dana-Farber Cancer Institute), Rizwan Haq(Dana-Farber Cancer Institute), F. Stephen Hodi(Dana-Farber Cancer Institute), Genevieve M. Boland(Massachusetts General Hospital), Ryan J. Sullivan(Massachusetts General Hospital), Dennie T. Frederick(Massachusetts General Hospital), Benchun Miao(Massachusetts General Hospital), Tabea Moll(Massachusetts General Hospital), Keith T. Flaherty(Massachusetts General Hospital), Meenhard Herlyn(The Wistar Institute), Russell W. Jenkins(Massachusetts General Hospital), Rohit Thummalapalli(Dana-Farber Cancer Institute), Monika S. Kowalczyk(Broad Institute), Israel Cañadas(Dana-Farber Cancer Institute), Bastian Schilling(Universitätsklinikum Würzburg), Adam N.R. Cartwright(Dana-Farber Cancer Institute), Adrienne Luoma(Dana-Farber Cancer Institute), Shruti Malu(Dana-Farber Cancer Institute), Patrick Hwu(The University of Texas MD Anderson Cancer Center), Chantale Bernatchez(The University of Texas MD Anderson Cancer Center), Marie-Andrée Forget(The University of Texas MD Anderson Cancer Center), David A. Barbie(Dana-Farber Cancer Institute), Alex K. Shalek(Broad Institute), Itay Tirosh(Broad Institute), Peter K. Sorger(Harvard University), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Dirk Schadendorf(Deutschen Konsortium für Translationale Krebsforschung), Bruce E. Johnson(Dana-Farber Cancer Institute), Asaf Rotem(Broad Institute), Orit Rozenblatt–Rosen(Broad Institute), Levi A. Garraway(Broad Institute), Charles H. Yoon(Brigham and Women's Hospital), Benjamin Izar(Broad Institute), Aviv Regev(Broad Institute)
Cited by 1,435Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis